Trump Scores Another Win Against New York's Corrupt 'Justice' System
Trump Has Decided Who He Won't Pick for FBI Director
Here's Pam Bondi's Stance on Illegal Immigration and Cartel Traffickers
CNN Legal Analyst Just Shredded Dems' Top Narrative Against Trump's AG Pick
Scott Presler to PA Dems Who Tried to Steal the Election: We're Coming...
Here's What Caused a Woman to Chop Up Her Father on Election Night
The Trump Counter-Revolution Is a Return to Sanity
One of Trump’s Biggest Allies Says He’s Never Getting Into Politics Again
MTG to Chair a New DOGE Subcommittee
Tom Cotton Issues 'Friendly Reminder' to ICC After Arrest Warrants for Netanyahu, Gallant
'Obstructionist Transition': Biden Administration Is 'Loosening Immigration Policies' on t...
New Legislation Puts the Department of Education on the Chopping Block
DOJ Calls for Google to Sell the Chrome Browser
Georgia Conducted a Hand Count Audit of Its Election Results. Guess What it...
Top Pollster Calls on Joe Biden to Resign
Tipsheet

Johnson & Johnson Seeks FDA Approval for Booster Shots for Adults

AP Photo/Matt Rourke

Johnson & Johnson reportedly filed a request with the Food and Drug Administration (FDA) to authorize booster shots for people 18 and older who’ve already received the company’s one-dose Wuhan coronavirus vaccine, ABC News reported Tuesday. 

Advertisement

The company reportedly submitted data on numerous booster intervals ranging from two months to six months. It did not formally recommend one to FDA regulators. 

As I previously covered, Johnson & Johnson announced last month that their single-dose vaccine has 94 percent efficacy against moderate-to-severe covid when a booster shot is administered two months after the initial dose. 

In a press release last month, Johnson & Johnson announced their plans for a booster shot and gave an update on the efficacy they were seeing with different intervals.

“When a booster of the Johnson & Johnson COVID-19 vaccine was given two months after the first shot, antibody levels rose to four to six times higher than observed after the single shot,” the press release reads. “When a booster of the Johnson & Johnson COVID-19 vaccine was given six months after the single shot, antibody levels increased nine-fold one week after the booster and continued to climb to 12-fold higher four weeks after the booster. All rises were irrespective of age.”

Advertisement

Currently, only the Pfizer vaccine booster shot has received Emergency Use Authorization from the FDA for adults ages 65 and older and individuals who are high-risk of severe COVID-19. The two-dose Pfizer vaccine against coronavirus is the only vaccine that has the FDA’s full and final approval. Both Johnson & Johnson and Moderna vaccines against covid have received Emergency Use Authorization from the FDA. 

“Both J&J and FDA have a sense of urgency because it’s COVID,” Dr. Mathai Mammen, head of research for J&J's Janssen unit, said to ABC News. “We want good data out there converted into action as soon as possible.”

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement